Clinical Trials Browser

Ganglioneuroblastoma × High-Energy Shock Waves × 90 days × Clear all

NCT02176967 2026-05-05

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Phase 3 Active not recruiting

Neuroblastoma, Ganglioneuroblastoma